268 related articles for article (PubMed ID: 8301149)
21. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
Long EO; LaVaute T; Pinet V; Jaraquemada D
J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
[TBL] [Abstract][Full Text] [Related]
22. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
23. Failure in expression of structurally altered (CYS164-->TYR) H-2Kb molecules is mitigated with high affinity peptide-ligand.
Tatake RJ; Zeff RA
Transplantation; 1995 May; 59(9):1343-9. PubMed ID: 7762072
[TBL] [Abstract][Full Text] [Related]
24. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
25. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
[TBL] [Abstract][Full Text] [Related]
26. The orientation of a T cell receptor to its MHC class II:peptide ligands.
Hong SC; Sant'Angelo DB; Dittel BN; Medzhitov R; Yoon ST; Waterbury PG; Janeway CA
J Immunol; 1997 Nov; 159(9):4395-402. PubMed ID: 9379037
[TBL] [Abstract][Full Text] [Related]
27. Cellular and subcellular distribution of PBP72/74, a peptide-binding protein that plays a role in antigen processing.
VanBuskirk AM; DeNagel DC; Guagliardi LE; Brodsky FM; Pierce SK
J Immunol; 1991 Jan; 146(2):500-6. PubMed ID: 1987275
[TBL] [Abstract][Full Text] [Related]
28. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
29. Characterization of transport of newly assembled, T cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface.
Pond L; Watts C
J Immunol; 1997 Jul; 159(2):543-53. PubMed ID: 9218568
[TBL] [Abstract][Full Text] [Related]
30. Single-chain MHC class II molecules induce T cell activation and apoptosis.
Rhode PR; Burkhardt M; Jiao J; Siddiqui AH; Huang GP; Wong HC
J Immunol; 1996 Dec; 157(11):4885-91. PubMed ID: 8943392
[TBL] [Abstract][Full Text] [Related]
31. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
Busch R; Vturina IY; Drexler J; Momburg F; Hämmerling GJ
Eur J Immunol; 1995 Jan; 25(1):48-53. PubMed ID: 7843252
[TBL] [Abstract][Full Text] [Related]
32. Analysis of MHC class II presentation of particulate antigens of B lymphocytes.
Vidard L; Kovacsovics-Bankowski M; Kraeft SK; Chen LB; Benacerraf B; Rock KL
J Immunol; 1996 Apr; 156(8):2809-18. PubMed ID: 8609400
[TBL] [Abstract][Full Text] [Related]
33. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
Peterson M; Sant AJ
J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
[TBL] [Abstract][Full Text] [Related]
34. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
[TBL] [Abstract][Full Text] [Related]
35. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains.
Théry C; Brachet V; Regnault A; Rescigno M; Ricciardi-Castagnoli P; Bonnerot C; Amigorena S
J Immunol; 1998 Sep; 161(5):2106-13. PubMed ID: 9725201
[TBL] [Abstract][Full Text] [Related]
36. Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo.
Nikcevich KM; Kopielski D; Finnegan A
J Immunol; 1994 Aug; 153(3):1015-26. PubMed ID: 7517970
[TBL] [Abstract][Full Text] [Related]
37. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.
Frandji P; Oskéritzian C; Cacaraci F; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
J Immunol; 1993 Dec; 151(11):6318-28. PubMed ID: 8245470
[TBL] [Abstract][Full Text] [Related]
38. A role for peptide in determining MHC class II structure.
Sadegh-Nasseri S; Germain RN
Nature; 1991 Sep; 353(6340):167-70. PubMed ID: 1653903
[TBL] [Abstract][Full Text] [Related]
39. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
40. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
Gautam AM; Yang M; Milburn PJ; Baker R; Bhatnagar A; McCluskey J; Boston T
J Immunol; 1997 Sep; 159(6):2782-8. PubMed ID: 9300699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
